CpG activates different innate cell types mainly signaling through MyD88 pathway via TLR9 (68), although it was reported that at high dose, CpG signaling through the TRIF pathway inhibited allergic bronchopulmonary aspergillosis (45). Here, MYD88 is linked to allergic bronchopulmonary aspergillosis.